Herranz’s Lab study published in Leukemia selected as a highlight of the year by the NCI December 24, 2020November 24, 2021 Daniel Herranz Uncategorized #NCIHighlights2020: In a @LeukemiaJnl study, @HerranzLab @RutgersCancer showed that inhibition of serine hydroxymethyltransferase (SHMT) suppresses cancer cell growth and synergizes with chemotherapy in experimental models of #leukemia. https://t.co/Jk7O9ytM38— NCI Division of Cancer Biology (@NCICancerBio) December 24, 2020